A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

November 30, 2012

Conditions
Orthostatic HypotensionParkinson's Disease
Interventions
DRUG

Droxidopa

100 mg and 200 mg capsules 100, 200, 300, 400, 500, 600mg TID dosing for up to 8 weeks of treatment

OTHER

Placebo

Placebo

Trial Locations (60)

10003

Beth Israel Medical Center, New York

10016

New York University, New York

11725

David L. Kreitzman, M.D., PC, Commack

12205

Upstate Clinical Research, LLC, Albany

12401

Kingston Neurological Associates, Kingston

13210

Neurological Care of CNY, Syracuse

15206

Clinical Trials Research Services LLC, Pittsburgh

15904

Ilumina Clinical Associates, Johnstown

23226

Neurological Associates, Inc., Richmond

23456

Sentara Neurology Specialists, Virginia Beach

27103

Clinical Trials of America Inc, Winston-Salem

27405

Guilford Neurologic Associates, Greensboro

28806

Asheville Neurology Specialists, PA, Asheville

30033

Neurology Specialists of Decatur Research Center, Decatur

30165

Prism Research Group, Rome

30329

Emory University, Atlanta

32174

Neurology Associates of Ormond Beach, Ormond Beach

32960

Vero Neurology, Vero Beach

33126

Pharmax Research Clinic, LLC, Miami

33407

Premiere Research Institute, West Palm Beach

33486

Parkinson's Disease & Movement Disorder Disoder, Boca Raton

33606

Tampa General University of South Florida, Tampa

33952

Neurostudies Inc., Port Charlotte

33980

Parkinson's Disease Treatment Center of Southwest Florida, Port Charlotte

34233

Lovelace Scientific Research, Sarasota

35007

Neurology Neurodiagnostic Lab, Alabaster

39564

Gulf Coast Neurology Center, PLLC, Ocean Springs

43210

Ohio State University Medical Center, Columbus

43614

University of Toledo, Toledo

45227

Community Research, Cincinnati

48377

Detroit Clinical Research Center, Novi

49684

Northern Michigan Neurology, Traverse City

60007

Alexian Brothers Hospital Network, Elk Grove Village

66604

Precise Clinical Research, Topeka

70403

North Oaks Health System, Hammond

74136

Movement Disorder Clinic of Oklahoma PLLC, Tulsa

84108

JM Neuroscience Research, Salt Lake City

85004

Xenoscience, Phoenix

85013

Barrow Neurology Clinic, Phoenix

85234

Neurological Physicians of Arizona, Gilbert

85351

Banner Health, Sun City

85718

Center for Neurosciences, Tucson

85741

Northwest Neuro Specialists P.L.L.C., Tucson

89102

University of Nevada School of Medicine, Las Vegas

90606

Neurology Consultants Medical Group, Whittier

91105

Neurosearch - Pasadena, Pasadena

91335

Neurosearch, Inc., Reseda

92064

Alliance Clinical Research, LLC, Poway

92653

Caring Clinical Research Incorporated, Laguna Hills

92663

Hoag Memorial Hospital, Presbyterian, Newport Beach

93003

Neurosearch II, Inc., Ventura

06824

Associated Neurologist of Southern Connecticut, PC, Fairfield

06106

Hartford Hospital, Hartford

06040

Eastern Connecticut Neurology Specialists, Manchester

02215

Harvard Vanguard Medical Associates, Boston

07823

Wellness and Research Center, Belvidere

08648

AdvanceMed Research, Lawrenceville

08755

Shore Neurology, Toms River

11040-1433

Parker Jewish Institute For Health Care and Rehabilitation Foundation, New Hyde Park

75390-9063

UT Southwestern Medical Center at Dallas, Dallas

Sponsors
All Listed Sponsors
lead

Chelsea Therapeutics

INDUSTRY